Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
NCT Number: NCT07787065
Chronic venous disease can cause pain, swelling, functional limitations, and reduced health-related quality of life. Ultrasound-guided foam sclerotherapy is commonly used to treat venous insufficiency. This randomized controlled trial evaluated whether a structured nursing intervention program, in addition to usual care, improved clinical severity and health-related quality of life in adults undergoing ultrasound-guided foam sclerotherapy at Vall d'Hebron University Hospital.
Participants were randomly assigned to usual care or to the nursing intervention program. The program included nursing assessment and education before the procedure, support during treatment, telephone follow-up on the following day, guidance on compression and self-care, access to telephone support, and scheduled follow-up. Clinical severity was assessed using the Venous Clinical Severity Score (VCSS), and health-related quality of life was evaluated using the Chronic Venous Insufficiency Questionnaire (CIVIQ-20). Satisfaction with care was also assessed in the intervention group.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Barcelona, 08035, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Accepts Healthy Volunteers: No Sex: All Gender Based: No Minimum Age: 18 Years Maximum Age: No Limit (N/A)
The structured nursing intervention program was delivered in addition to usual care. It included a nursing consultation before the procedure with clinical assessment and individualized education; support during the sclerotherapy procedure; telephone follow-up on the following day; guidance on compression therapy, self-care, and warning signs; access to telephone support; and scheduled follow-up at three weeks and six months. Ultrasound-guided foam sclerotherapy was clinically indicated background treatment and was not assigned by the study.
Time frame: Baseline and 6 months after the procedure
Clinical severity was assessed using the Venous Clinical Severity Score (VCSS). The scale consists of 10 clinical domains scored from 0 to 3, producing a total score ranging from 0 to 30. Higher scores indicate greater venous disease severity. A decrease from baseline indicates clinical improvement.
Time frame: Baseline and 6 months after the procedure
Health-related quality of life was assessed using the 20-item Chronic Venous Insufficiency Questionnaire (CIVIQ-20), which evaluates pain, physical, psychological, and social dimensions. The global score is transformed to a scale from 0 to 100, with higher scores indicating better health-related quality of life. A positive change from baseline indicates improvement.
Time frame: At 6 months after the procedure
Patient satisfaction was assessed using the 13-item Baker Consultation Satisfaction Questionnaire. The questionnaire was administered only to participants in the nursing intervention group because it evaluated satisfaction with the structured nursing intervention program, which was not received by the usual care group. Items are rated on a 5-point Likert scale and evaluate three dimensions: professional care, professional relationship, and consultation time. Items were coded according to the questionnaire scoring method, and mean scores were calculated for each dimension. Higher scores indicate greater satisfaction after accounting for reverse-scored items.
Hospital Universitari Vall d'Hebron Research Institute
Other
Eficacia de un Programa de intervención Enfermera Para Pacientes Sometidos a Escleroterapia de Vena Safena Interna
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06683586
Chronic Venous Disease
São Paulo, Brazil
View Trial DetailsNCT07236307
Chronic Venous Disease, Drainage
Porto, Portugal
View Trial DetailsNCT05612217
CVD, Chronic Venous Disease
Moscow, Russia
View Trial DetailsNCT04574375
Chronic Venous Disease
Suresnes, France
View Trial Details